Cynosure Company Profile (NASDAQ:CYNO)

About Cynosure (NASDAQ:CYNO)

Cynosure logoCynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:CYNO
  • CUSIP: 23257720
  • Web: www.cynosure.com
Average Prices:
  • 50 Day Moving Avg: $62.47
  • 200 Day Moving Avg: $50.89
  • 52 Week Range: $39.90 - $66.65
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 32.51
  • P/E Growth: 0.00
Profitability:
  • Net Margins: 3.56%
  • Return on Equity: 6.86%
  • Return on Assets: 5.35%
Debt:
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 3.28%
  • Quick Ratio: 2.54%
Misc:
  • Average Volume: 1.17 million shs.
  • Beta: 1.65
 

Frequently Asked Questions for Cynosure (NASDAQ:CYNO)

What is Cynosure's stock symbol?

Cynosure trades on the NASDAQ under the ticker symbol "CYNO."

How were Cynosure's earnings last quarter?

Cynosure, Inc. (NASDAQ:CYNO) posted its quarterly earnings data on Tuesday, July, 26th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.07. The business earned $110.30 million during the quarter, compared to analyst estimates of $101.31 million. Cynosure had a net margin of 3.56% and a return on equity of 6.86%. The company's revenue was up 31.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.30 earnings per share. View Cynosure's Earnings History.

Where is Cynosure's stock going? Where will Cynosure's stock price be in 2017?

7 analysts have issued 12-month price targets for Cynosure's shares. Their forecasts range from $40.00 to $66.00. On average, they anticipate Cynosure's stock price to reach $58.57 in the next twelve months. View Analyst Ratings for Cynosure.

Who are some of Cynosure's key competitors?

Who owns Cynosure stock?

Cynosure's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Glenmede Trust Co. NA (0.00%), Scout Investments Inc. (0.00%), FNY Partners Fund LP (0.00%) and Teachers Retirement System of The State of Kentucky (0.00%). Company insiders that own Cynosure stock include Brian M Barefoot, Douglas J Delaney, Ettore V Biagioni, Michael R Davin and Timothy W Baker. View Institutional Ownership Trends for Cynosure.

Who sold Cynosure stock? Who is selling Cynosure stock?

Cynosure's stock was sold by a variety of institutional investors in the last quarter, including Teachers Retirement System of The State of Kentucky. Company insiders that have sold Cynosure stock in the last year include Brian M Barefoot, Douglas J Delaney, Michael R Davin and Timothy W Baker. View Insider Buying and Selling for Cynosure.

Who bought Cynosure stock? Who is buying Cynosure stock?

Cynosure's stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc. and FNY Partners Fund LP. View Insider Buying and Selling for Cynosure.

How do I buy Cynosure stock?

Shares of Cynosure can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cynosure's stock price today?

One share of Cynosure stock can currently be purchased for approximately $66.00.


MarketBeat Community Rating for Cynosure (NASDAQ CYNO)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  177 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  256
MarketBeat's community ratings are surveys of what our community members think about Cynosure and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cynosure (NASDAQ:CYNO) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $58.57 (11.26% downside)

Analysts' Ratings History for Cynosure (NASDAQ:CYNO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/28/2017AegisReiterated RatingHold$66.00N/AView Rating Details
2/16/2017Northland SecuritiesReiterated RatingOutperform$60.00N/AView Rating Details
2/14/2017Northcoast ResearchUpgradeSell -> NeutralN/AView Rating Details
2/14/2017Maxim GroupDowngradeBuy -> Hold$66.00N/AView Rating Details
10/28/2016Leerink SwannReiterated RatingOutperform$63.00 -> $60.00N/AView Rating Details
10/26/2016Stifel NicolausReiterated RatingBuy$62.00 -> $58.00N/AView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Cynosure (NASDAQ:CYNO)
Earnings by Quarter for Cynosure (NASDAQ:CYNO)
Earnings History by Quarter for Cynosure (NASDAQ:CYNO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q416$0.41$0.44$119.97 million$122.10 millionViewListenView Earnings Details
10/25/2016Q316$0.28$0.29$101.11 million$106.40 millionViewListenView Earnings Details
7/26/2016Q216$0.29$0.36$101.31 million$110.30 millionViewListenView Earnings Details
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details
2/9/2016Q415$0.36$0.42$95.01 million$102.40 millionViewListenView Earnings Details
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.30$82.71 million$83.70 millionViewListenView Earnings Details
5/5/2015Q1$0.17$0.15$70.87 million$74.90 millionViewListenView Earnings Details
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details
7/29/2014Q214$0.30$0.32$71.15 million$72.60 millionViewListenView Earnings Details
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details
10/23/2012$0.12$0.25ViewN/AView Earnings Details
7/24/2012$0.12$0.20ViewN/AView Earnings Details
5/1/2012($0.02)$0.06ViewN/AView Earnings Details
2/14/2012$0.05$0.08ViewN/AView Earnings Details
10/25/2011$0.04($0.06)ViewN/AView Earnings Details
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cynosure (NASDAQ:CYNO)
2017 EPS Consensus Estimate: $1.63
2018 EPS Consensus Estimate: $2.02
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.23$0.26$0.24
Q2 20173$0.40$0.44$0.43
Q3 20173$0.38$0.42$0.40
Q4 20173$0.51$0.61$0.57
Q1 20181$0.34$0.34$0.34
Q2 20181$0.51$0.51$0.51
Q3 20181$0.50$0.50$0.50
Q4 20181$0.67$0.67$0.67
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Cynosure (NASDAQ:CYNO)
Insider Ownership Percentage: 2.90%
Insider Trades by Quarter for Cynosure (NASDAQ:CYNO)
Institutional Ownership by Quarter for Cynosure (NASDAQ:CYNO)
Insider Trades by Quarter for Cynosure (NASDAQ:CYNO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2016Douglas J DelaneyVPSell7,875$45.00$354,375.00View SEC Filing  
11/22/2016Michael R DavinChairmanSell16,284$45.00$732,780.00View SEC Filing  
8/30/2016Brian M BarefootDirectorSell21,000$51.66$1,084,860.00View SEC Filing  
8/15/2016Michael R DavinChairmanSell12,062$53.35$643,507.70View SEC Filing  
8/15/2016Timothy W BakerCFOSell5,834$53.35$311,243.90View SEC Filing  
8/11/2016Michael R DavinChairmanSell4,222$53.18$224,525.96View SEC Filing  
8/11/2016Timothy W BakerCFOSell2,041$53.19$108,560.79View SEC Filing  
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.40View SEC Filing  
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.89View SEC Filing  
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.60View SEC Filing  
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.90View SEC Filing  
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.99View SEC Filing  
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.16View SEC Filing  
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.76View SEC Filing  
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.77View SEC Filing  
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.14View SEC Filing  
4/13/2016Michael R DavinCEOSell72$45.00$3,240.00View SEC Filing  
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.64View SEC Filing  
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.59View SEC Filing  
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.04View SEC Filing  
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.22View SEC Filing  
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.99View SEC Filing  
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.20View SEC Filing  
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.00View SEC Filing  
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Cynosure (NASDAQ:CYNO)
Latest Headlines for Cynosure (NASDAQ:CYNO)
Source:
DateHeadline
bizjournals.com logoAsia-Pacific Aesthetic Lasers and Energy Devices Market Outlook to 2023
www.bizjournals.com - May 16 at 4:39 PM
prnewswire.com logoMedical Aesthetic Devices Market - Middle East and North Africa Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
www.prnewswire.com - May 11 at 10:18 PM
americanbankingnews.com logoCynosure (CYNO) Earning Somewhat Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - May 3 at 3:28 PM
marketwatch.com logoAesthetics Combination Therapy Market Revenues to Reach US$ 3.69 Bn by 2024 - Persistence Market Research
www.marketwatch.com - May 3 at 8:46 AM
americanbankingnews.com logoCynosure, Inc. (CYNO) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 2 at 10:48 PM
americanbankingnews.com logoCynosure (CYNO) Receives Media Impact Rating of 0.12
www.americanbankingnews.com - April 29 at 9:35 PM
bizjournals.com logoLiposuction Devices - Global Market Outlook (2016-2022)
www.bizjournals.com - April 27 at 5:10 PM
americanbankingnews.com logoSomewhat Negative News Coverage Very Unlikely to Impact Cynosure (CYNO) Stock Price
www.americanbankingnews.com - April 26 at 1:52 PM
americanbankingnews.com logoCynosure (CYNO) Earning Somewhat Positive News Coverage, Analysis Finds
www.americanbankingnews.com - April 23 at 2:09 PM
americanbankingnews.com logoCynosure, Inc. (CYNO) to Release Earnings on Monday
www.americanbankingnews.com - April 21 at 11:26 PM
americanbankingnews.com logoCynosure (CYNO) Receiving Positive Media Coverage, Report Shows
www.americanbankingnews.com - April 20 at 8:59 PM
bloomberg.com logoTrump to Nominate Quarles for Fed's Top Regulatory Post, Source Says
www.bloomberg.com - April 18 at 12:07 PM
americanbankingnews.com logoSomewhat Negative Press Coverage Likely to Impact Cynosure (CYNO) Stock Price
www.americanbankingnews.com - April 15 at 2:13 PM
prnewswire.com logoSouth Korea Aesthetic Lasers and Energy Devices Market Outlook to 2023
www.prnewswire.com - April 11 at 4:29 PM
bizjournals.com logoGermany Aesthetic Lasers and Energy Devices Market Outlook to 2023
www.bizjournals.com - April 10 at 4:30 PM
americanbankingnews.com logoCynosure, Inc. (CYNO) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - April 5 at 5:19 PM
americanbankingnews.com logoAegis Reiterates "Hold" Rating for Cynosure, Inc. (CYNO)
www.americanbankingnews.com - March 28 at 11:23 AM
americanbankingnews.com logoCynosure, Inc. (CYNO) Short Interest Down 29.3% in March
www.americanbankingnews.com - March 28 at 8:26 AM
streetinsider.com logoForm 4 CYNOSURE INC For: Mar 22 Filed by: Hatsopoulos Marina - StreetInsider.com
www.streetinsider.com - March 25 at 11:01 AM
streetinsider.com logoForm 4 CYNOSURE INC For: Mar 22 Filed by: Hatsopoulos Marina
www.streetinsider.com - March 24 at 9:55 PM
streetinsider.com logoForm SC 14D9/A CYNOSURE INC Filed by: CYNOSURE INC
www.streetinsider.com - March 24 at 4:53 PM
marketwatch.com logoDermatology Devices Market Worth $25 Billion by 2025 | CAGR: 12.7%: Grand View Research, Inc.
www.marketwatch.com - March 23 at 5:11 PM
biz.yahoo.com logoCYNOSURE INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure t
biz.yahoo.com - March 23 at 5:11 PM
finance.yahoo.com logoMRLB U.S. Sales Jump 38% As Aesthetic Market Heats Up
finance.yahoo.com - March 22 at 4:46 PM
americanbankingnews.com logoCynosure, Inc. (CYNO) Downgraded by Aegis to Hold
www.americanbankingnews.com - March 21 at 7:10 AM
americanbankingnews.com logoAegis Lowers Cynosure, Inc. (CYNO) to Hold
www.americanbankingnews.com - March 18 at 8:45 AM
americanbankingnews.com logoCynosure, Inc. (CYNO) Short Interest Update
www.americanbankingnews.com - March 11 at 7:33 AM
americanbankingnews.com logoCynosure, Inc. (CYNO) Given Average Rating of “Hold” by Analysts
www.americanbankingnews.com - March 10 at 12:38 PM
finance.yahoo.com logoScar Treatment Market Worth $34.5 Billion by 2025 | Growth Rate: 9.7%: Grand View Research, Inc.
finance.yahoo.com - March 8 at 5:23 PM
finance.yahoo.com logoCYNOSURE INC Financials
finance.yahoo.com - March 4 at 5:02 PM
streetinsider.com logoForm SC 14D9/A CYNOSURE INC Filed by: CYNOSURE INC - StreetInsider.com
www.streetinsider.com - March 4 at 2:49 AM
biz.yahoo.com logoCYNOSURE INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 1 at 1:14 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cynosure, Inc. - CYNO
finance.yahoo.com - February 28 at 4:50 PM
biz.yahoo.com logoCYNOSURE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - February 22 at 9:00 AM
businesswire.com logoCYNOSURE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Hologic ... - Business Wire (press release)
www.businesswire.com - February 18 at 8:08 AM
rttnews.com logoCynosure Inc. (CYNO) Leaped To A New High After Purchased By Hologic
www.rttnews.com - February 16 at 7:01 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
finance.yahoo.com - February 16 at 7:01 PM
finance.yahoo.com logoCYNOSURE (CYNO) Alert: Johnson & Weaver, LLP Launches an ... - Yahoo Finance
finance.yahoo.com - February 16 at 2:00 PM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An ... - Business Wire (press release)
www.businesswire.com - February 16 at 2:00 PM
fool.com logoHere's Why Cynosure, Inc. is Soaring Today - Motley Fool
www.fool.com - February 16 at 2:00 PM
finance.yahoo.com logoCynosure (CYNO) to be Acquired by Hologic in $1.65B Deal
finance.yahoo.com - February 16 at 2:00 PM
investopedia.com logoHologic to Acquire Cynosure for $1.65 Billion
www.investopedia.com - February 16 at 2:00 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Investors To Contact The Firm For Additional Information
finance.yahoo.com - February 16 at 2:00 PM
finance.yahoo.com logoHarwood Feffer LLP Announces Investigation of Cynosure, Inc.
finance.yahoo.com - February 16 at 2:00 PM
finance.yahoo.com logoCYNOSURE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Hologic, Inc. May be Unfair to Shareholders
finance.yahoo.com - February 16 at 2:00 PM
biz.yahoo.com logoCYNOSURE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws
biz.yahoo.com - February 14 at 10:27 PM
finance.yahoo.com logoCYNOSURE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
finance.yahoo.com - February 14 at 10:27 PM
finance.yahoo.com logoHologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and ...
finance.yahoo.com - February 14 at 5:26 PM
nasdaq.com logoCynosure Inc. (CYNO) Has Jumped To A New High After Bought By Hologic
www.nasdaq.com - February 14 at 5:25 PM
marketwatch.com logoCynosure's stock rockets after buyout deal with Hologic
us.rd.yahoo.com - February 14 at 5:25 PM

Social

Chart

Cynosure (CYNO) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff